G Medical Innovations Holdings Ltd. (GMVD) News
Filter GMVD News Items
GMVD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest GMVD News From Around the Web
Below are the latest news stories about G MEDICAL INNOVATIONS HOLDINGS LTD that investors may wish to consider to help them evaluate GMVD as an investment opportunity.
G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick resultsThe first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for purchasing by consumers during Q3-2022 online as well as at popular retail locations and pharmacies The tests offered to the consumers utilize FDA registered componentsTest kit prices range from $50-$260, all provide results within days by CLIA certified labsAdditional testing kits to be announced l |
G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Nasdaq Minimum Bid Price NotificationIrvine, California, June 17, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, has received a written notice (the “Notice”) from Nasdaq Stock Market LLC, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Lis |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayGood morning, traders! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayGood morning, investors! |
G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Announces Share Repurchase ProgramIrvine, California, May 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”) today announced that its board of directors has authorized a share repurchase program to acquire up to $1 million of the Company's ordinary shares (the “Repurchase Plan”). The Company may purchase ordinary shares from time to time in the open market, through privately negotiated transactions, or any other legally permissible ways, depending on market conditions, share price, tr |
G Medical Warns On Missing Q1 Sales Guidance Of $30MView more earnings on GMVDSee more from BenzingaCDC Looking Into 180 Cases Of Unexplained Pediatric Acute Hepatitis: CNBCThird Largest Player In Baby Formula Jumps In To Ease Shortage In USDon't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. |
G Medical Innovations (NASDAQ: GMVD) Provides Update Regarding its Forecast for Q1 2022 RevenuesIrvine, CA – May 18, 2022 – G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”), today announced that it will not meet its forecast of $30 million in revenues for the first quarter o... |
G Medical Innovations Holdings Ltd Announces Closing of $8 Million Private PlacementTEL AVIV and NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company prov... |
(Correction) G Medical Innovations Holdings Ltd Announces $7.5 Million Private PlacementTEL AVIV and NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor to purchase 5,000,000 ordinary shares (or ordinary shares equivalents) in a private p |
G Medical Innovations Holdings Ltd Announces $7.5 Million Private Placement Priced At-the-Market Under Nasdaq RulesTEL AVIV and NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company prov... |